Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 38 min ago
PreprintCC BY-NC-NDbioRxiv

BAP1 loss and PRAME expression converge to remodel the tumor-immune ecosystem during uveal melanoma progression

  1. 1Department of Ophthalmology and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center

Abstract

Uveal melanoma (UM) is characterized by a small number of recurrent genetic alterations that determine metastatic propensity. BAP1 loss and PRAME expression define the dominant prognostic axes in UM, yet how they promote malignant progression remains unclear. We profiled 190,535 cells from normal uvea, uveal nevus, primary and metastatic UM using single-cell transcriptomics, T cell receptor sequencing, spatial transcriptomics and isogenic perturbation models. Normal melanocytes, nevus cells and UM cells formed a transcriptional continuum marked by loss of differentiation and emergence of neural crest-like, stress-responsive, hypoxic-glycolytic and immune-interacting states. BAP1 loss and PRAME expression imposed distinct but convergent immunoregulatory programs, inducing interferon and TNF-NFkB signaling and MHC-I expression, with HLA-E showing the strongest response. These alterations were accompanied by macrophage and CD8+ T cell remodeling. PRAME-enriched tumor regions formed spatially organized niches enriched for macrophages and plasma cells. These findings define BAP1 loss and PRAME expression as distinct but convergent axes of tumor-immune coevolution and nominate HLA-E as a candidate mediator of immune resistance.

Related

  1. Multimodal macroscopic brain abnormalities in schizophrenia converge on insular, mediofrontal, and sensorimotor cortices and link with glial cell expression but not with recent evolutionary change
    M. Thalhammer, P. Rossmueller, C. Meng +3
    medRxivPreprintCC BY-NDFull textPsychiatry & mental healthmedRxiv
  2. Pannexin 1 Ablation Disrupts Cell Cycle Progression and Compromises the Structure of Melanoma Tumours
    S. E. Leighton, D. Johnston, K. Barr +11
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  3. Spatially resolved multimodal hallmarks of response to neoadjuvant immunotherapies in the melanoma ecosystem in 2D and 3D
    Z. Liu, X. Song, W.-S. Chen +21
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  4. p38α orchestrates BRAFV600E-melanoma progression and immunotherapy response via tumor fitness and immune microenvironment modulation.
    Paula Granado-Martínez, Kimberley McGrail, Roberto Orsenigo +15
    Nature communicationsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  5. Endothelial AMBRA1 loss contributes to vascular dysregulation facilitating metastatic progression in early-stage melanoma
    L. Walker, R. Stout, M. Di Rienzo +11
    bioRxivPreprintCC BYFull textOncologybioRxiv
BibTeX
@misc{dollar2026bap1,
  title = {{BAP1 loss and PRAME expression converge to remodel the tumor-immune ecosystem during uveal melanoma progression}},
  author = {J. J. Dollar and X. Liu and M. Singh and M. Sorouri and J. N. Kuznetsoff and S. Salazar and A. Cruz and C. L. Decatur and Z. M. Correa and J. W. Harbour},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.23.752454},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.23.752454v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - BAP1 loss and PRAME expression converge to remodel the tumor-immune ecosystem during uveal melanoma progression
AU  - J. J. Dollar
AU  - X. Liu
AU  - M. Singh
AU  - M. Sorouri
AU  - J. N. Kuznetsoff
AU  - S. Salazar
AU  - A. Cruz
AU  - C. L. Decatur
AU  - Z. M. Correa
AU  - J. W. Harbour
PY  - 2026
DA  - 2026/09/23
PB  - bioRxiv
DO  - 10.64898/2026.09.23.752454
UR  - https://www.biorxiv.org/content/10.64898/2026.09.23.752454v1
AB  - Uveal melanoma (UM) is characterized by a small number of recurrent genetic alterations that determine metastatic propensity. BAP1 loss and PRAME expression define the dominant prognostic axes in UM, yet how they promote malignant progression remains unclear. We profiled 190,535 cells from normal uvea, uveal nevus, primary and metastatic UM using single-cell transcriptomics, T cell receptor sequencing, spatial transcriptomics and isogenic perturbation models. Normal melanocytes, nevus cells and UM cells formed a transcriptional continuum marked by loss of differentiation and emergence of neural crest-like, stress-responsive, hypoxic-glycolytic and immune-interacting states. BAP1 loss and PRAME expression imposed distinct but convergent immunoregulatory programs, inducing interferon and TNF-NFkB signaling and MHC-I expression, with HLA-E showing the strongest response. These alterations were accompanied by macrophage and CD8+ T cell remodeling. PRAME-enriched tumor regions formed spatially organized niches enriched for macrophages and plasma cells. These findings define BAP1 loss and PRAME expression as distinct but convergent axes of tumor-immune coevolution and nominate HLA-E as a candidate mediator of immune resistance.
ER  -